| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| quinacrine | cytosolic phospholipase a2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Leishmaniasis Cutaneous[MeSHID:D016773] Pleural Effusion Malignant[MeSHID:D016066] Giardiasis[MeSHID:D005873] |
NA | investigational | inhibitor |
| quinacrine | 85/88 kda calcium-independent phospholipase a2 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Leishmaniasis Cutaneous[MeSHID:D016773] Pleural Effusion Malignant[MeSHID:D016066] Giardiasis[MeSHID:D005873] |
NA | investigational | inhibitor |
| quinacrine | inactive phospholipase c-like protein 1 | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Leishmaniasis Cutaneous[MeSHID:D016773] Pleural Effusion Malignant[MeSHID:D016066] Giardiasis[MeSHID:D005873] |
NA | investigational | inhibitor |
| quinacrine | dna | small molecule | NA | drugbank | Disease Management[MeSHID:D019468] Leishmaniasis Cutaneous[MeSHID:D016773] Pleural Effusion Malignant[MeSHID:D016066] Giardiasis[MeSHID:D005873] |
NA | investigational | intercalation |
| click here to return to the previous page | ||||||||